Blood Clot Cases: Denmark Suspends Use Of AstraZeneca For 3 More Weeks

Aizbah KhanWeb Editor

25th Mar, 2021. 10:02 pm
AstraZeneca vaccine delays Australia

In Denmark, further investigation into the possible link between abnormal cases of blood clots and a possible link between the vaccines has led to the suspension of the use of the anti-COVID-19 AstraZeneca vaccine for another three weeks.

According to reports, Denmark was one of the first European countries to stop using the vaccine this month due to fears of a blood clot-related to AstraZeneca.

Most of the countries that had temporarily imposed sanctions on AstraZeneca have now resumed using the vaccine following recommendations from the European Union’s Drug Watch and the World Health Organization (WHO).

But Danish officials say they cannot rule out the link between the vaccine and the rare disease in two local cases.

According to officials, they are also reviewing other cases in Europe in this regard.

“Our final decision on the further use of the COVID-19 vaccine, AstraZeneca, is uncertain,” said Soren Brostrom, director of the Danish Health Authority.

“There has been a lot of research in this regard, but we have not yet reached a conclusion, so we have decided to extend the suspension of vaccine use,” he said.

According to the Health Agency’s website, if the reuse of AstraZeneca is not approved after 3 weeks, the vaccination process in Denmark will be delayed by 4 weeks.

The decision to extend the suspension was made in part so as not to jeopardize the public’s confidence in the COVID-19 vaccine.

“I need to be able to tell people with great clarity, conviction and openness that they can trust the vaccine that we are not only offering but also recommending,” said Soren Brostrom.

“That’s why we’re taking precautions,” he said.

It is estimated that about 1.5 million people in Denmark had been vaccinated before the use of AstraZeneca was stopped.

In Denmark, 500,000 people have been vaccinated with the Pfizer-Biotech vaccine and 37,000 people have been vaccinated with Moderna.

Last week, the European Medicines Agency and the World Health Organization declared AstraZeneca safe.

The first reports of blood clots in people using the AstraZeneca vaccine came from Austria, which caused a wave of concern against a specific batch of vaccines, and vaccinations were stopped there.

Following Austria, the vaccine was temporarily suspended last week in Austria, Denmark, Norway and Iceland, and on March 14 by the Netherlands and Ireland.

On March 15, the three largest EU countries, France, Germany and Italy, as well as Spain, Latvia and Slovenia, suspended AstraZeneca vaccinations due to these concerns, and on March 16, Sweden and Luxembourg were added to the list.

The World Health Organization (WHO) said on March 17 that vaccinations to prevent COVID-19 do not reduce the risk of disease or death from other causes, and that platelet loss is quite common.

The World Health Organization (WHO) has said that the benefits of vaccines outweigh the potential risks, and recommended that vaccinations be continued.

 

Adsense 300 x 250